Argent Biopharma Ltd Cash Flow Quality Index
Argent Biopharma Ltd cash flow quality index. Argent Biopharma Ltd (RGT) has a Cash Flow Quality Index of -4.11x as of September 2018. Operating cash flow of AU$-1.34 Million is below net income of AU$326.24K, suggesting accrual-heavy earnings not yet converted to cash. See RGT free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Argent Biopharma Ltd (2006–2011)
Cash flow quality index of Argent Biopharma Ltd from 2006 to 2011. Historical Cash Flow Quality Index for Argent Biopharma Ltd across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore RGT cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Argent Biopharma Ltd Cash Flow Quality Index by Year (2006–2011)
Argent Biopharma Ltd cash flow quality index by year from 2006 to 2011. Year-by-year earnings quality comparison for Argent Biopharma Ltd. For the full cash flow conversion analysis, see how efficiently does Argent Biopharma Ltd generate cash.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2011 | -0.18x | AU$-338.82K | AU$1.94 Million | ▼ -180.3% |
| 2006 | 0.22x | AU$41.00K | AU$188.00K | — |